CIPRO

This brand name is authorized in Albania, Canada, Germany, Singapore, Turkey, United States

Active ingredients

The drug CIPRO contains one active pharmaceutical ingredient (API):

1 Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. Read about Ciprofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CIPRO Film-coated tablet / Oral suspension kit	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 189/390
Country: CA	Health Products and Food Branch	Identifier(s): 02237514, 02247916, 02251787
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00036357, 00819148, 00819154, 00819183, 01969938, 01969967, 01969973, 01969996, 02709091, 02709116, 02709122, 02709139, 02709145, 02709151, 04954067, 04954073, 04954096, 06934809, 06934815, 08440170, 08440187, 08440193, 08440201, 17952377, 17952383
Country: SG	Health Sciences Authority	Identifier(s): 14414P, 14415P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699578090418, 8699578090425, 8699578090432, 8699578090531, 8699578610418, 8699578690410, 8699578690427
Country: US	FDA, National Drug Code	Identifier(s): 50419-754, 50419-758